Paul Kinnon Named President, Chief Executive Officer and Director
Transgenomic, Inc. (OTCBB: TBIO) today announced that Craig Tuttle, Chief Executive Officer of Transgenomic, will be presenting at the Craig-Hallum Capital Group’s 2013 Alpha Select...
Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic Believed to be first clinical test to identify variants of four enzymes...
Conference Call to Be Held at 5:00 PM Eastern Time Today
Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast: What: Transgenomic, Inc. Second Quarter 2013 Financial Results and...
Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast: What: Transgenomic, Inc. Second Quarter 2013 Financial...
Transgenomic, Inc. (OTCBB: TBIO) and ApoCell, Inc. today announced the results of a research collaboration with the University of Texas MD Anderson Cancer Center that coupled ApoCell’s...
Transgenomic, Inc. (OTCBB: TBIO) today reported financial results for the first quarter ended March 31, 2013 and provided a business update. First Quarter Financial Results Net...
Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast: What: Transgenomic, Inc. First Quarter 2013 Financial Results and...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.305 | -18.2089552239 | 1.675 | 1.7 | 1.3 | 5930 | 1.49188621 | CS |
4 | -1.48 | -51.9298245614 | 2.85 | 3.15 | 1.3 | 14038 | 2.33456364 | CS |
12 | 1.12 | 448 | 0.25 | 3.95 | 0.25 | 51391 | 3.33066399 | CS |
26 | 1.12 | 448 | 0.25 | 3.95 | 0.25 | 45885 | 3.33066399 | CS |
52 | 1.12 | 448 | 0.25 | 3.95 | 0.25 | 44302 | 3.33066399 | CS |
156 | 1.12 | 448 | 0.25 | 3.95 | 0.25 | 37787 | 3.33066399 | CS |
260 | 1.12 | 448 | 0.25 | 3.95 | 0.25 | 34724 | 3.33066399 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約